Blog Series: NIAID-DVI
Tetravalent dengue purified inactivated vaccine (DPIV): status of the GSK/FIOCRUZ/US Army dengue vaccine candidate
Alexander Schmidt
So some of these talks I processed more than others, there were quite a few after all, so some postings will be more detailed than others. That being said, this is one of those lesser 'noted' talks so essentially you'll be hearing a lot from the abstract and I'll do my best to augment what I can with further research links.
Lucky for me there are two great slide sets freely available about GSK's DPIV as well as their mission within the dengue vaccine 'initiative'. They state not to reproduce any of the content/slides at the bottom of all the slides without permission so I'll just be linking them.
Slide Presentation 1: Rationale for and Status of GSK/FIOCRUZ/WRAIR new
Slide Presentation 2: Tetravalent Dengue Purified Inactivated Vaccine (DPIV)
